BPG is committed to discovery and dissemination of knowledge
Article Citation
Becker K, Xu Y. Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutation. World J Clin Oncol 2014; 5(4): 560-567 [PMID: 25302160 DOI: 10.5306/wjco.v5.i4.560]
Please LOGIN to submit a new comment.
Write to the Help Desk